Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) said its AI-powered Safe Entry Station, which accurately screen for various physiological conditions non-invasively, has received pivotal clinical validation data from one of the largest government hospital groups in India.
"Our team is diligently working towards the goal of Safe Entry being in thousands of hospital triages across the world. We believe our technology will drastically improve patient care and reduce the strain on already over-extended healthcare workers,” Dr Rahul Kushwah, chief operating officer at Predictmedix in a statement.
"We're thrilled with the successful clinical findings from MGM Healthcare and are aggressively moving forward with commercializing Safe Entry as an automated, non-invasive healthcare tool powered by artificial intelligence," he added.
READ: Predictmedix raises fresh capital as eyes opportunities for its healthcare AI
The Safe Entry Station is a walk-thru system where an individual stands in front of the unit for 2-3 seconds while the multi-spectral imaging cameras gather the necessary information to determine the physiological state of the individual. Parameters like temperature, heart rate and respiration rate are collected non-invasively and the AI/ML algorithms compute a result. Vitals hold key insight into an individual's state, whether they're dealing with health complications, influenza, fatigue or even impairment. Safe Entry does not capture or store personal identity information, the company explained.
MGM Healthcare, one of the largest groups of medical universities in India, said in its independent clinical report that Safe Entry is ideal for hospital settings to screen patients for various conditions.
“We found Safe Entry to be very accurate at reading vital signs such as temperature, heart rate and respiration rate. Our overall assessment of Safe Entry has been quite positive as it has been used in various settings during the peak of the Covid outbreak within our hospital. Safe Entry was deployed at MGM for over 18 months, making several upgrades to their AI algorithms and models and now reached a mature stage of commercialization," MGM’s report was quoted as saying.
Predictmedix is an emerging provider of rapid health screening and remote patient care solutions globally. The company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue or various mental illnesses.
Contact the author at jon.hopkins@proactiveinvestors.com